 Product Service News
July 8, 2024
July 08, 2024 Applied Materials, Inc. has recently introduced innovative materials engineering advancements that have the potential to significantly enhance the performance-per-watt of computer systems. These breakthroughs aim to enable copper wiring to scale down to the 2nm logic node and even beyond. With this l...
|
Partnership
July 8, 2024
Amarin s Flagship Medication VASCEPA Receives Regulatory Approval in Mainland China, Paving the Way for Cardiovascular Risk ReductionIn a groundbreaking development, Amarin s strategic partner, EddingPharm, has received regulatory approval from the National Medical Products Administration (NMPA) for VASCEPA (Icosape...
|
Product Service News
July 8, 2024
BrightSpring Health Services: A Triple Crown in Accreditations, Strengthening Its Commitment to Quality Care By | CSIMarket.com LOUISVILLE, Ky. BrightSpring Health Services, Inc. (NASDAQ: BTSG), a prominent player in the home and community-based health care services sector, recently announced a significant mil...
|
|
 Product Service News
July 8, 2024
Enphase Energy Initiates U.S. Manufacturing with IQ8 Commercial Microinverters Amid Mixed Financial Signals In a significant move to bolster domestic production and catalyze the renewable energy sector, Enphase Energy, Inc. (NASDAQ: ENPH), a prominent global energy technology enterprise, announced the inaugural ship...
 Contract
July 8, 2024
In the fast-paced aerospace sector, maintaining a leading edge demands continuous innovation, investment, and reliability. CPI Aerostructures, Inc. (CPI Aero) is proving to be an exemplary player in this arena, recently marking several notable achievements that promise to fortify its market position and future growt...
|
|
Our most Popular Articles
|
Management Announcement
July 15, 2024
In an exciting development for Eton Pharmaceuticals, the company recently announced that the U.S. Food and Drug Administration (FDA) has accepted their New Drug Application (NDA) for ET-400, a Hydrocortisone Oral Solution. The Prescription Drug User Fee Act (PDUFA) target action date for the drug s approva...
|
Announcement
May 28, 2024
Major Legal Battle Unfolds as Pomerantz and Rosen Law Firms Announce Class Action Lawsuits Against QuidelOrtho Corporation (QDEL)In a significant development within the corporate and legal communities, QuidelOrtho Corporation (NASDAQ: QDEL) finds itself at the epicenter of two major class action lawsuits. These leg...
|
Management Announcement
June 14, 2024
Global technology company JOYY Inc. (Nasdaq: YY) recently announced the successful results of its repurchase right offer for its 1.375% Convertible Senior Notes due 2026. The offer saw a significant response, with a total of US$405,445,000 aggregate principal amount of the 2026 Notes surrendered and accept...
|
|
|
Company News
|
Partnership
July 8, 2024
Amarin s Flagship Medication VASCEPA Receives Regulatory Approval in Mainland China, Paving the Way for Cardiovascular Risk ReductionIn a groundbreaking development, Amarin s strategic partner, EddingPharm, has received regulatory approval from the National Medical Products Administration (NMPA) for VASCEPA (Icosape...
|
Product Service News
July 8, 2024
BrightSpring Health Services: A Triple Crown in Accreditations, Strengthening Its Commitment to Quality Care By | CSIMarket.com LOUISVILLE, Ky. BrightSpring Health Services, Inc. (NASDAQ: BTSG), a prominent player in the home and community-based health care services sector, recently announced a significant mil...
|
Clinical Study
July 8, 2024
The NEST-IN1 Phase 2b Clinical Study conducted by HilleVax aimed to assess the efficacy of HIL-214 in infants. However, disappointing results have led the company to discontinue the drug s further development in this specific trial. This article presents an analysis of the topline data from the study, highlighting ...
|
|
|
Company News
 Management Announcement
July 8, 2024
|
Company News
 Partnership
July 8, 2024
|
Company News
Contract
July 8, 2024
|
More Company News
|
Clinical Study
July 8, 2024
|
Clinical Study
July 8, 2024
|
Financing Agreement
July 8, 2024
|
Management Announcement
July 8, 2024
|
Product Service News
July 8, 2024
|
Business Update
July 8, 2024
|
Business Update
July 8, 2024
|
Business Update
July 8, 2024
|
Announcement
July 7, 2024
|
Announcement
July 7, 2024
|
|
|
|
Related News
|
Business Update
|
Business Update
|
|
Stocks
|
Stocks on the Move
|
Stocks on the Move
|
Stocks on the Move
|
|
|
|
Business News
|
|
Product Service News
Enphase Energy Initiates U.S. Manufacturing with IQ8 Commercial Microinverters Amid Mixed Financial Signals In a significant move to bolster domestic production and catalyze the renewable energy sector, Enphase Energy, Inc. (NASDAQ: ENPH), a prominent global energy technology enterprise, announced the inaugural ship...
|
|
Contract
In the fast-paced aerospace sector, maintaining a leading edge demands continuous innovation, investment, and reliability. CPI Aerostructures, Inc. (CPI Aero) is proving to be an exemplary player in this arena, recently marking several notable achievements that promise to fortify its market position and future growt...
|
 Clinical Study
NewAmsterdam Pharma recently announced the successful completion of patient enrollment for its pivotal Phase 3 TANDEM clinical trial. This trial aims to evaluate the efficacy and safety of a fixed-dose combination of Obicetrapib and Ezetimibe in patients diagnosed with Familial Hypercholesterolemia (HeFH), Atheroscl...
|
 Business Update
In recent groundbreaking developments, Adicet Bio, a clinical stage biotechnology company specializing in allogeneic gamma delta T cell therapies, has received significant recognition and support from the U.S. Food and Drug Administration (FDA). Their experimental treatments, ADI-270 and ADI-001, have been granted F...
|
|
Product Service News
July 08, 2024 Applied Materials, Inc. has recently introduced innovative materials engineering advancements that have the potential to significantly enhance the performance-per-watt of computer systems. These breakthroughs aim to enable copper wiring to scale down to the 2nm logic node and even beyond. With this l...
|
Our Most Popular Articles
|
 Management Announcement
In an exciting development for Eton Pharmaceuticals, the company recently announced that the U.S. Food and Drug Administration (FDA) has accepted their New Drug Application (NDA) for ET-400, a Hydrocortisone Oral Solution. The Prescription Drug User Fee Act (PDUFA) target action date for the drug s approva...
|
|
Announcement
Major Legal Battle Unfolds as Pomerantz and Rosen Law Firms Announce Class Action Lawsuits Against QuidelOrtho Corporation (QDEL)In a significant development within the corporate and legal communities, QuidelOrtho Corporation (NASDAQ: QDEL) finds itself at the epicenter of two major class action lawsuits. These leg...
|
 Management Announcement
Global technology company JOYY Inc. (Nasdaq: YY) recently announced the successful results of its repurchase right offer for its 1.375% Convertible Senior Notes due 2026. The offer saw a significant response, with a total of US$405,445,000 aggregate principal amount of the 2026 Notes surrendered and accept...
|
More News
|
 Partnership
Amarin s Flagship Medication VASCEPA Receives Regulatory Approval in Mainland China, Paving the Way for Cardiovascular Risk ReductionIn a groundbreaking development, Amarin s strategic partner, EddingPharm, has received regulatory approval from the National Medical Products Administration (NMPA) for VASCEPA (Icosape...
|
 Product Service News
BrightSpring Health Services: A Triple Crown in Accreditations, Strengthening Its Commitment to Quality Care By | CSIMarket.com LOUISVILLE, Ky. BrightSpring Health Services, Inc. (NASDAQ: BTSG), a prominent player in the home and community-based health care services sector, recently announced a significant mil...
|
 Clinical Study
The NEST-IN1 Phase 2b Clinical Study conducted by HilleVax aimed to assess the efficacy of HIL-214 in infants. However, disappointing results have led the company to discontinue the drug s further development in this specific trial. This article presents an analysis of the topline data from the study, highlighting ...
|
 Management Announcement
Fanhua Inc. Grants Share Options to Key Employees to Foster Long-Term Success
GUANGZHOU, China - Fanhua Inc., a leading independent technology-driven financial services provider in China, has recently announced that its board of directors has approved the grant of share options to certain key employees. Thi...
|
|
Partnership
In a noteworthy collaboration, CellProthera and BioCardia have achieved success in their Phase II trial of ProtheraCytes for the treatment of Acute Myocardial Infarction (AMI). This breakthrough brings hope for improved therapy options and potentially life-saving advancements for patients suffering from AMI. This ar...
|
 Contract
Pluri, a leading player in the agriculture and food production industry, has recently unveiled a groundbreaking initiative aimed at enhancing the global supply of sustainable vegetables. The company has inked a $1 million proof of concept agreement with a vision to develop innovative production methods, shorten supp...
|
|
Clinical Study
CSIMarket.com presents an overview of recent updates from Bio-Path Holdings, focusing on their clinical progress and expansion plans in the treatment of various cancer indications. The article highlights the positive results from ongoing phase 2 combination studies of Prexigebersen, specifically for the treatment ...
|
|
Clinical Study
iTeos Therapeutics, a clinical-stage biopharmaceutical company dedicated to revolutionizing immuno-oncology treatment options, has recently made significant progress in its pursuit of developing novel therapeutics. The company has reported the initiation of the GALAXIES Lung-301 Phase 3 study, evaluating belrestotug...
|
 Financing Agreement
Sunrise Realty Trust Invests $14.1 Million in Senior Loan for an Austin Multi-Family Development, Revitalizing Senior Living in Southwest Austin
In a major move towards the revitalization of senior living options in southwest Austin, Sunrise Realty Trust, Inc. (SUNS), an institutional commercial real estate lend...
|
 Management Announcement
Plymouth Industrial REIT, a leading real estate investment trust specializing in industrial properties, has provided an activity update for the second quarter of 2024 and has announced details for its second-quarter earnings conference call. The company achieved a return on average invested assets (ROI) of 1.61...
|
 Product Service News
In a groundbreaking move, Futu Holdings Limited, a leading tech-driven online brokerage and wealth management platform, recently announced the uplift of its Type 1 license to include virtual asset dealing services. This upgrade was granted by the Hong Kong Securities and Futures Commission (SFC), enabling Futu Secur...
|
 Business Update
UAS Drone Corp. Advances Commercial Activity Following Successful Pilot Completion with IEC, Despite Revenue Decrease in Q3 2023In a bid to enhance its standing in the robotics technology and drone solutions industry, UAS Drone Corp. (OTCQB: USDR) has recently announced significant advancements in its commercial act...
|
|
Business Update
In a significant development that underscores its accelerating progress, Sky Harbour Group Corporation (NYSE: SKYH, SKYH WS) has announced its inclusion in the Russell 2000 Index, a key benchmark for small-cap stocks. Effective from the market’s opening on July 1st, this move comes as part of the 2024 Russell indexes annual reconstitution.The Russell 2000 Index, managed by FTSE Russell, is a widely followed index that tracks 2000 of the smallest companies in the Russell 3000 Index, which measures the performance of the 3000 largest U.S. companies. Inclusion in the Russell 2000 Index is a sought-after milestone for many emerging companies, given the index s influence and the visibility it provides among the investment community.
|
|
Business Update
Motorola Solutions, a leading provider of mission-critical communication and software solutions, has announced the opening of a new Research and Development (R&D) Centre in Cork, Ireland. This centre, expected to create 200 high-skilled jobs, will primarily focus on designing software for the company s land mobile r...
|
 Announcement
Shareholder Alert: Pomerantz Law Firm Investigates Potential Claims on Behalf of Hesai Group Investors By CSIMarket.com New York, July 7, 2024 This morning, Pomerantz LLP, a noted law firm specializing in shareholder rights, announced an investigation into claims on behalf of investors in Hesai Group (NASDAQ:...
|
 Announcement
Class Action Lawsuit Filed Against Humana Inc.: What Shareholders Need to Know By CSIMarket.com Staff Writer On July 7, 2024, Pomerantz LLP announced the filing of a class action lawsuit against Humana Inc. (NYSE: HUM), alleging financial misrepresentation and investor deception. Shareholders who acquired Humana ...
|
|
|
|
|
